Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions (Q34995358)

5 August 2017

title

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions (English)

1 reference

5 August 2017

Janel Dockter

1

1 reference

5 August 2017

Astrid Schroder

2

1 reference

5 August 2017

Craig Hill

3

1 reference

5 August 2017

Leah Guzenski

4

1 reference

5 August 2017

Joseph Monsonego

5

1 reference

5 August 2017

Cristina Giachetti

6

1 reference

5 August 2017

publication date

1 July 2009

1 reference

Journal of Clinical Virology

5 August 2017

published in

1 reference

5 August 2017

volume

45 Suppl 1

1 reference

5 August 2017

page(s)

S55-61

1 reference

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Human papillomavirus genotype specificity of hybrid capture 2

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Comparison of AMPLICOR and Hybrid Capture II assays for high risk HPV detection in normal and abnormal liquid-based cytology: use of INNO-LiPA Genotyping assay to screen the discordant results

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Prospective evaluation of the Hybrid Capture 2 and AMPLICOR human papillomavirus (HPV) tests for detection of 13 high-risk HPV genotypes in atypical squamous cells of uncertain significance

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Performance of the Roche AMPLICOR human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Comparison of the AMPLICOR human papillomavirus test and the hybrid capture 2 assay for detection of high-risk human papillomavirus in women with abnormal PAP smear

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Population-based study of screening test performance indices of three human papillomavirus DNA tests

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Detection of human papillomavirus genotypes among high-risk women: a comparison of hybrid capture and linear array tests

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Invader human papillomavirus (HPV) type 16 and 18 assays as adjuncts to HPV screening of cervical papanicolaou smears with atypical squamous cells of undetermined significance.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

A comparison of two methods to determine the presence of high-risk HPV cervical infections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Detection of high-risk human papillomavirus E6 and E7 oncogene transcripts in cervical scrapes by nested RT-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Probable Inference, the Law of Succession, and Statistical Inference

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Note on the sampling error of the difference between correlated proportions or percentages

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Genotyping of human papillomavirus in liquid cytology cervical specimens by the PGMY line blot assay and the SPF(10) line probe assay

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

Classification of papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2809%2970009-5

7 January 2021

10.1016/S1386-6532(09)70009-5

Identifiers

DOI

1 reference

5 August 2017

1 reference